Hot Paths

Eli Lilly lowers starting dose costs for Zepbound on direct purchase platform (LLY:NYSE)

Woman using injection pen to administer weight loss drug

Eli Lilly (LLY) is cutting prices for starting doses of Zepbound single-dose vials on its LillyDirect direct-to-consumer platform.

With a valid prescription, patients can get a 2.5 mg vial for $299 per month, down from $349 previously, and a 5 mg vial for $399, lower than $499 previously. All

Exit mobile version